Pictet Asset Management
ROIV icon

Pictet Asset Management’s Roivant Sciences ROIV Stock Holding History

Pictet Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123M Buy
3,468,340
+795,107
+30% +$23.5M 0.12% 194
2026
Q1 		$74M Buy
2,673,233
+360,797
+16% +$9.27M 0.08% 253
2025
Q4 		$50.2M Buy
2,312,436
+2,052,693
+790% +$40.5M 0.05% 328
2025
Q3 		$3.92M Sell
259,743
-13,555
-5% -$168K ﹤0.01% 816
2025
Q2 		$3.11M Sell
273,298
-91,625
-25% -$993K ﹤0.01% 831
2025
Q1 		$3.77M Sell
364,923
-562,547
-61% -$6.08M ﹤0.01% 834
2024
Q4 		$11M Sell
927,470
-175,418
-16% -$2.07M 0.01% 643
2024
Q3 		$12.7M Sell
1,102,888
-119,041
-10% -$1.36M 0.01% 597
2024
Q2 		$12.9M Sell
1,221,929
-2,486,157
-67% -$27.2M 0.01% 582
2024
Q1 		$39.6M Buy
3,708,086
+991,868
+37% +$10.7M 0.04% 356
2023
Q4 		$30.5M Buy
2,716,218
+600,513
+28% +$5.85M 0.03% 386
2023
Q3 		$24.7M Buy
+2,115,705
New +$23.9M 0.03% 410

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Pictet Asset Management's ROIV Position: Q2 2026 in Review

Pictet Asset Management increased its Roivant Sciences (ROIV) stake by 30% in Q2 2026, buying an estimated $23.5M and bringing the position to 3,468,340 shares worth $123M. The position accounts for 0.12% of the portfolio, ranked #194.

Pictet Asset Management first reported a position in ROIV in Q3 2023 and has held it in 12 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Pictet Asset Management held 3,468,340 shares of Roivant Sciences worth $123M as of Q2 2026.
  • Pictet Asset Management bought 795,107 Roivant Sciences shares in Q2 2026, an estimated $23.5M.
  • Roivant Sciences made up 0.12% of Pictet Asset Management's portfolio in Q2 2026, its #194 holding.
  • Pictet Asset Management first reported a position in Roivant Sciences in Q3 2023 and has held it in 12 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.